Related Experiment Video
Updated: May 11, 2026
09:43
An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
A virtual look at Epstein-Barr virus infection: biological interpretations
Karen A Duca1, Michael Shapiro, Edgar Delgado-Eckert
1Virginia Bioinformatics Institute, Virginia Polytechnic and State University, Blacksburg, Virginia, USA.
Plos Pathogens
|October 24, 2007
Summary
Computer simulations offer new insights into Epstein-Barr virus (EBV) infection dynamics. The PathSim model accurately reproduces EBV infection, aiding in understanding disease progression and developing targeted therapies.
Area of Science:
- Computational biology
- Virology
- Mathematical modeling
Background:
- Computer simulation and mathematical modeling are increasingly used for biological insights.
- Epstein-Barr virus (EBV) is a persistent human pathogen linked to significant diseases.
- A detailed biological model of EBV infection exists, explaining its complex properties.
Purpose of the Study:
- To develop and validate an agent-based computer simulation (PathSim) of EBV infection.
- To assess the utility of simulations in understanding EBV infection dynamics and disease.
- To identify key factors influencing EBV infection outcomes and associated diseases.
Main Methods:
- Developed PathSim, an agent-based computer simulation of EBV infection.
- Simulated infection on a virtual grid representing tonsils and peripheral circulation.
- Utilized a user-friendly visual interface to present simulation results.
Main Results:
- PathSim accurately reproduced quantitative and qualitative aspects of acute and persistent EBV infection.
- The simulation demonstrated predictive power in validation experiments.
- Identified critical switch points in infection dynamics and parameter sets for EBV-associated diseases.
Conclusions:
- Agent-based simulations, like PathSim, are powerful tools for studying EBV infection.
- These simulations, combined with traditional research methods, can enhance understanding and control of EBV.
- Simulation-driven insights can guide the development of targeted anti-viral therapies for EBV.
